211 related articles for article (PubMed ID: 29024434)
1. WHO guide on the economic evaluation of influenza vaccination.
Newall AT; Chaiyakunapruk N; Lambach P; Hutubessy RCW
Influenza Other Respir Viruses; 2018 Mar; 12(2):211-219. PubMed ID: 29024434
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
[TBL] [Abstract][Full Text] [Related]
3. Influenza cost and cost-effectiveness studies globally--a review.
Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
[TBL] [Abstract][Full Text] [Related]
4. Program cost analysis of influenza vaccination of health care workers in Albania.
Pallas SW; Ahmeti A; Morgan W; Preza I; Nelaj E; Ebama M; Levin A; Lafond KE; Bino S
Vaccine; 2020 Jan; 38(2):220-227. PubMed ID: 31669063
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.
Poland GA; Rottinghaus ST; Jacobson RM
Vaccine; 2001 Mar; 19(17-19):2216-20. PubMed ID: 11257336
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine programs for children in low- and middle-income countries: current status and way forward.
Ortiz JR; Neuzil KM
Expert Rev Vaccines; 2019 Jul; 18(7):711-724. PubMed ID: 31226895
[No Abstract] [Full Text] [Related]
7. Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.
Jit M; Newall AT; Beutels P
Hum Vaccin Immunother; 2013 Apr; 9(4):834-40. PubMed ID: 23357859
[TBL] [Abstract][Full Text] [Related]
8. Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.
Salleras L; Navas E; Torner N; Prat AA; Garrido P; Soldevila N; Domínguez A
Hum Vaccin Immunother; 2013 Mar; 9(3):707-11. PubMed ID: 23295894
[TBL] [Abstract][Full Text] [Related]
9. Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
Thommes EW; Kruse M; Kohli M; Sharma R; Noorduyn SG
Hum Vaccin Immunother; 2017 Apr; 13(4):867-876. PubMed ID: 27858509
[TBL] [Abstract][Full Text] [Related]
10. Costs and effectiveness of influenza vaccination: a systematic review.
D'Angiolella LS; Lafranconi A; Cortesi PA; Rota S; Cesana G; Mantovani LG
Ann Ist Super Sanita; 2018; 54(1):49-57. PubMed ID: 29616674
[TBL] [Abstract][Full Text] [Related]
11. Economic value of influenza vaccination.
de Waure C; Veneziano MA; Cadeddu C; Capizzi S; Specchia ML; Capri S; Ricciardi W
Hum Vaccin Immunother; 2012 Jan; 8(1):119-29. PubMed ID: 22251999
[TBL] [Abstract][Full Text] [Related]
12. Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
Vaccine; 2019 Apr; 37(15):2051-2056. PubMed ID: 30871927
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries.
Lall D; Cason E; Pasquel FJ; Ali MK; Narayan KM
COPD; 2016; 13(1):93-9. PubMed ID: 26418892
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the health economic consequences of quadrivalent influenza vaccination.
de Boer PT; van Maanen BM; Damm O; Ultsch B; Dolk FCK; Crépey P; Pitman R; Wilschut JC; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):249-265. PubMed ID: 28613092
[TBL] [Abstract][Full Text] [Related]
15. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
Hendriks J; Hutubessy RCW; Grohmann G; Torelli G; Friede M; Kieny MP
Vaccine; 2018 Jun; 36(28):3993-3997. PubMed ID: 29866617
[TBL] [Abstract][Full Text] [Related]
16. Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.
Dawa J; Emukule GO; Barasa E; Widdowson MA; Anzala O; van Leeuwen E; Baguelin M; Chaves SS; Eggo RM
BMC Med; 2020 Aug; 18(1):223. PubMed ID: 32814581
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review.
Boccalini S; Bechini A; Moscadelli A; Paoli S; Schirripa A; Bonanni P
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):911-922. PubMed ID: 33930994
[No Abstract] [Full Text] [Related]
18. Medical economics in the field of influenza--past, present and future.
Szucs TD
Virus Res; 2004 Jul; 103(1-2):25-30. PubMed ID: 15163484
[TBL] [Abstract][Full Text] [Related]
19. Health and economic impact of the seasonal influenza vaccination programme in England.
Baguelin M; Jit M; Miller E; Edmunds WJ
Vaccine; 2012 May; 30(23):3459-62. PubMed ID: 22446636
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
